Page last updated: 2024-11-12

bufokinin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bufokinin: binds mammalian tachykinin receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10486632
CHEMBL ID2347503
MeSH IDM0289952

Synonyms (5)

Synonym
bdbm50432253
bufokinin
CHEMBL2347503
lys-pro-arg-pro-asp-gln-phe-tyr-gly-leu-met.nh2
lys-pro-arg-pro-asp-gln-phe-tyr-gly-leu-met.nh(2)

Research Excerpts

Overview

Bufokinin is a substance P-related tachykinin peptide with potent spasmogenic actions. It is isolated from the intestine of the cane toad, Bufo marinus.

ExcerptReferenceRelevance
"1. Bufokinin is a substance P-like neuropeptide and potent spasmogen isolated from the intestine of the cane toad Bufo marinus. "( Bufokinin: actions and distribution in the toad cardiovascular system.
Burcher, E; Comis, A; Liu, L; Shang, F, 2000
)
2.37
"Bufokinin is a substance P-related tachykinin peptide with potent spasmogenic actions, isolated from the intestine of the cane toad, Bufo marinus. "( Structure-activity studies of bufokinin, substance P and their C-terminal fragments at bufokinin receptors in the small intestine of the cane toad, Bufo marinus.
Burcher, E; Liu, L; Murray, M, 2002
)
2.05
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuromedin-K receptorHomo sapiens (human)IC50 (µMol)2.99000.00100.28822.9900AID738397
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuromedin-K receptorHomo sapiens (human)EC50 (µMol)0.01070.00020.08960.7930AID738396
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
tachykinin receptor signaling pathwayNeuromedin-K receptorHomo sapiens (human)
positive regulation of heart rateNeuromedin-K receptorHomo sapiens (human)
response to estradiolNeuromedin-K receptorHomo sapiens (human)
regulation of dopamine metabolic processNeuromedin-K receptorHomo sapiens (human)
response to cocaineNeuromedin-K receptorHomo sapiens (human)
positive regulation of blood pressureNeuromedin-K receptorHomo sapiens (human)
regulation of feeding behaviorNeuromedin-K receptorHomo sapiens (human)
positive regulation of uterine smooth muscle contractionNeuromedin-K receptorHomo sapiens (human)
positive regulation of flagellated sperm motilityNeuromedin-K receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
protein bindingNeuromedin-K receptorHomo sapiens (human)
tachykinin receptor activityNeuromedin-K receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
plasma membraneNeuromedin-K receptorHomo sapiens (human)
dendrite membraneNeuromedin-K receptorHomo sapiens (human)
neuronal cell body membraneNeuromedin-K receptorHomo sapiens (human)
sperm midpieceNeuromedin-K receptorHomo sapiens (human)
plasma membraneNeuromedin-K receptorHomo sapiens (human)
sperm midpieceNeuromedin-K receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID738395Displacement of [125I]-BH-SP from NK1R (unknown origin) transfected in CHO cells at 10 uM by gamma counting analysis2013Bioorganic & medicinal chemistry, Apr-15, Volume: 21, Issue:8
Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
AID738397Displacement of ([125I]-His3, MePhe7)-NKB from NK3R (unknown origin) transfected in CHO cells by gamma counting analysis2013Bioorganic & medicinal chemistry, Apr-15, Volume: 21, Issue:8
Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
AID738396Agonist activity at NK3R (unknown origin) transfected in CHO cells assessed as calcium influx at 10 mM2013Bioorganic & medicinal chemistry, Apr-15, Volume: 21, Issue:8
Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
AID738394Displacement of [125I]-NKA from NK2R (unknown origin) transfected in CHO cells at 10 uM by gamma counting analysis2013Bioorganic & medicinal chemistry, Apr-15, Volume: 21, Issue:8
Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's6 (66.67)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.99 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]